By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oramed Pharmaceuticals Inc. 

2 Elza Street

Jerusalem    93706  Israel
Phone: 011-972-54-7909058 Fax: 011-972-2-6792336



Company News
Oramed (ORMP) Signs Up To $50 Million Licensing And Investment Agreements For Oral Insulin Capsule In China 11/30/2015 6:38:38 AM
Oramed (ORMP) To Present At The Aegis Capital Growth Conference 10/1/2015 10:15:36 AM
Oramed (ORMP) Patent Allowed In The US For Oral Administration Of Proteins 9/24/2015 11:57:16 AM
Oramed (ORMP) Completes Randomization Of Over 50% Of Patients In Phase Ilb Oral Insulin Study 9/9/2015 6:56:09 AM
Oramed (ORMP) To Present At The Rodman & Renshaw Global Investment Conference 9/4/2015 6:39:14 AM
Sinopharm Capital-Hefei Signs Letter Of Intent With Oramed (ORMP) For $50,000,000 Investment And Licensing Deal In China 7/7/2015 6:47:05 AM
Week In Review: Zhongheng Pays $52 Million For Oramed (ORMP)'s Diabetes Drugs 7/6/2015 9:49:30 AM
Oramed (ORMP) Secures Toehold in China With $52M Investment From Chinese Firm 7/2/2015 6:16:44 AM
Oramed Pharmaceuticals Inc. (ORMP) Enrolls First Patient In Its Phase Ilb Oral Insulin Study 6/30/2015 7:38:55 AM
Oramed Pharmaceuticals Inc. (ORMP) Submits Protocol To U.S. FDA For Its Phase Ilb Oral Insulin Study 6/30/2015 7:31:19 AM